Price: quote on request. Your total cost is quoted in writing per case.
We reply within one business day
Get my quote

Major depressive disorder (major depression): US-approved treatments and how Gulf families can access them

A plain guide for families in the Gulf, checked against US FDA labels, Gulf drug registers and published medical research.

Reviewed by the Reserve Meds clinical operations team on 17 October 2026.

Major depressive disorder: the short answer

The US FDA has approved eight medicines on this page for major depressive disorder, each for specific patients. Four of them are on at least one Gulf register we checked, so ask your hospital about local supply first. Otherwise the hospital can request a named-patient import. Reserve Meds is a digital health company. We do not diagnose or prescribe.

  • US FDA-approved medicines on this page: Trintellix, Exxua, Auvelity, Rexulti, Vraylar, Caplyta, Spravato and Zurzuvae.
  • Gulf registration (checked 17 October 2026): see each medicine below.
  • Legal route: Local supply where listed; otherwise a named-patient import request filed by the treating hospital.
  • Price: Quote on request.

What is major depressive disorder?

Major depressive disorder, often called major depression, is a serious mood disorder. It is more than feeling sad for a few days. It affects how a person thinks and feels and can make sleeping, eating or working hard. Symptoms include a depressed mood or a loss of interest that affects daily life and lasts at least two weeks.[1]

Depression has many possible causes, including genetic, biological, environmental and psychological factors. It can happen at any age and is more common in women. It often occurs together with long-term illnesses such as diabetes, cancer or heart disease, and each can make the other worse.[1]

Depression often needs long-term treatment, and getting help early can make symptoms easier to manage. Treatment usually combines talk therapy and medicines chosen by a doctor. If a first medicine does not help enough, doctors may change the dose, switch medicines or add another one.[1]

Major depressive disorder in the Gulf

A national phone survey of 6,015 adults in Saudi Arabia in 2022 found that 12.7% were at risk of major depressive disorder, while only 1.5% of participants were currently diagnosed and treated for depression. The authors called for earlier detection and easier access to treatment.[2]

US FDA-approved medicines for major depressive disorder

Each medicine below is approved in the US for a specific group of patients. The wording summarizes the current US label. Your specialist decides whether any of them is right for the patient.

  • Trintellix (vortioxetine)
    FDA-approved for adults with major depressive disorder. It is a tablet taken once a day.[3]
    Gulf registers: Saudi Arabia: listed in the SFDA drugs list (as Brintellix). Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list (as Brintellix). Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[4, 5]
    Country guides: Saudi Arabia, UAE, Egypt, Jordan, India, Pakistan
  • Exxua (gepirone)
    FDA-approved for adults with major depressive disorder. It is an extended-release tablet.[6]
    Gulf registers: Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: not found by brand name in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[4, 5]
    Country guides: Saudi Arabia, UAE
  • Auvelity (dextromethorphan hydrobromide, bupropion hydrochloride)
    FDA-approved for adults with major depressive disorder. It combines dextromethorphan and bupropion in one tablet.[7]
    Gulf registers: Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: not found by brand name in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[4, 5]
  • Rexulti (brexpiprazole)
    FDA-approved for adults with major depressive disorder as an add-on to an antidepressant. It is also approved for other conditions.[8]
    Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[4, 5]
    Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Egypt, Jordan, India, Pakistan
  • Vraylar (cariprazine)
    FDA-approved for adults with major depressive disorder as an add-on to an antidepressant. It is also approved for schizophrenia and bipolar disorder.[9]
    Gulf registers: Saudi Arabia: listed in the SFDA drugs list (as Reagila). Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list (as Reagila). Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[4, 5]
    Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Egypt, Jordan, India, Pakistan
  • Caplyta (lumateperone)
    FDA-approved for adults with major depressive disorder as an add-on to an antidepressant. It is also approved for schizophrenia and bipolar depression.[10]
    Gulf registers: Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: not found by brand name in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[4, 5]
    Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman, Egypt, Jordan, Turkey, India, Pakistan
  • Spravato (esketamine hydrochloride)
    FDA-approved for adults with major depressive disorder who have acute suicidal thoughts or behavior, together with an oral antidepressant, and adults with treatment-resistant depression. It is a nasal spray used under supervision in a certified health care setting.[11]
    Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[4, 5]
    Country guides: Saudi Arabia, UAE, Oman, Lebanon, Turkey, India, Pakistan
  • Zurzuvae (zuranolone)
    FDA-approved for adults with postpartum depression, a form of depression after childbirth. It is a capsule taken for 14 days.[12]
    Gulf registers: Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: not found by brand name in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[4, 5]

How families in the Gulf can access these medicines

If the medicine is listed in your country. Ask your specialist and the hospital pharmacy about local supply first. A listing does not mean every hospital stocks the medicine, and another brand of the same medicine may also be registered, but local supply is usually the fastest route and you may not need us.

If it is not registered. The usual legal route is a named-patient request: the treating hospital, on your specialist's written request, asks the national regulator for permission to import the medicine for one patient, using the US FDA approval as the reference. In Saudi Arabia the SFDA Special Access Program guidance covers these requests; in Bahrain, NHRA Circular 41 of 2020 sets the procedure. Other Gulf countries have their own procedures, which the hospital pharmacy confirms.[13, 14] Once approval is in place, Reserve Meds arranges supply through a US-licensed pharmaceutical wholesale partner to the hospital pharmacy.

Who does what

  • Your treating specialist decides whether a medicine is right for the patient and writes the letter.
  • The hospital checks local supply, files any import request, and gives the treatment safely.
  • The national regulator decides whether to approve the import of a medicine that is not registered.
  • The manufacturer decides where its medicine can be supplied, especially for cell and gene therapies.
  • Reserve Meds helps organize records, coordinates US supply through our wholesale partner, shipping and updates to your family. We do not give medical advice.

Documents you will usually need

  • A letter from the treating specialist with the diagnosis, past treatments and why the medicine is being considered
  • Reports that confirm the diagnosis, such as laboratory, genetic, imaging or pathology results, translated into English where needed
  • Recent clinic notes and a list of current medicines
  • For a hospital import request: the prescription, the hospital's request form and the written consent of the patient or guardian
  • Proof of the US FDA approval and the US prescribing information (we can supply these)

We give you a written timeline estimate once we see the hospital file. The regulator, the treatment center and the manufacturer set their own timelines.

What treatment costs

Quote on request. Your total cost depends on the medicine, the dose, shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

How Reserve Meds helps

Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We help your doctor and hospital prepare the file, arrange US supply and temperature-controlled shipping once approval is in place, and keep your family updated. We coordinate access to FDA-approved medicines only. Investigational medicines are only available through a manufacturer's expanded-access program requested by the treating physician; we can explain that route, but we do not supply them.

Ask us about treatment for major depressive disorder

Tell us the medicine, your country and a WhatsApp or phone number. We reply within one business day. On WhatsApp we usually reply the same day.

Include the country code, for example +966 or +971.
Message us on WhatsApp

No account needed. We reply within one business day. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

Frequently asked questions

Is there an FDA-approved treatment for major depressive disorder?

Yes. The medicines on this page have US FDA approval for specific groups of patients: Trintellix, Exxua, Auvelity, Rexulti, Vraylar, Caplyta, Spravato and Zurzuvae. The exact conditions are in each US label and are summarized above. Your specialist decides whether any of them fits.

Is Trintellix available in Saudi Arabia or the UAE?

Saudi Arabia: listed in the SFDA drugs list (as Brintellix). Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list (as Brintellix). Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register. A listing in Abu Dhabi does not show federal UAE status.

How can a family in the Gulf get Trintellix?

Ask the treating hospital about local supply first. If it is not available, the hospital can file a named-patient import request with the national regulator on your specialist's written request. Once approved, we arrange US supply to the hospital pharmacy.

How much does treatment cost?

Quote on request. Your total cost, including the medicine, shipping, import steps and coordination, is quoted in writing for your case before you commit. No hidden charges.

Is depression treated with medicine alone?

Not usually. MedlinePlus explains that depression often needs long-term treatment and that getting help early helps manage symptoms. Doctors commonly combine talk therapy with medicine. Your own doctor decides what fits your situation.

What if I have thoughts of harming myself?

Seek help now. Contact your local emergency number or go to the nearest emergency department. Reserve Meds cannot provide crisis support. Our role is limited to helping with access to prescribed medicines.

Sources for the last two answers: [1]

Sources

Checked on 17 October 2026. Labels, registers and regulator rules change. Your hospital pharmacy confirms the current position before filing.

  1. MedlinePlus (US National Library of Medicine): Depression
  2. Alhabeeb et al. National screening for anxiety and depression in Saudi Arabia 2022. Front Public Health 2023 (PubMed 37441650)
  3. DailyMed (US National Library of Medicine): Trintellix (vortioxetine) US prescribing information, version published 11 March 2025
  4. SFDA: Drugs List, public register (all 9,173 entries checked by brand name on 17 October 2026)
  5. Department of Health Abu Dhabi: drug code list Drugs.xlsx (release 26 September 2026, effective 2 October 2026)
  6. DailyMed (US National Library of Medicine): Exxua (gepirone) US prescribing information, version published 15 July 2026
  7. DailyMed (US National Library of Medicine): Auvelity (dextromethorphan hydrobromide, bupropion hydrochloride) US prescribing information, version published 19 August 2026
  8. DailyMed (US National Library of Medicine): Rexulti (brexpiprazole) US prescribing information, version published 28 May 2026
  9. DailyMed (US National Library of Medicine): Vraylar (cariprazine) US prescribing information, version published 20 August 2026
  10. DailyMed (US National Library of Medicine): Caplyta (lumateperone) US prescribing information, version published 1 June 2026
  11. DailyMed (US National Library of Medicine): Spravato (esketamine hydrochloride) US prescribing information, version published 24 September 2026
  12. DailyMed (US National Library of Medicine): Zurzuvae (zuranolone) US prescribing information, version published 17 June 2026
  13. SFDA: Special Access Program (SAP) guidance, version 1.0
  14. NHRA Bahrain: Circular No. (41) of 2020, procedures for importing non-registered medicines and pharmaceutical products

Related

This page is general health information, not medical advice. It does not replace a consultation with your doctor.

WhatsApp